Supreme Group Appoints Dr. Ramon Felciano to Guide AI in Life Sciences
Supreme Group has appointed Dr. Ramon Felciano as an independent board member to guide AI innovation in life sciences marketing, announced in a press release. Dr. Felciano, a seasoned AI strategist, has a notable history of building and scaling AI businesses, including founding Ingenuity, a pioneer in AI-driven genome interpretation.
Dr. Felciano's expertise will be instrumental in advancing Supreme Group's proprietary AI platform, Supreme Intelligence, which is designed specifically for healthcare and life sciences. His previous experience includes leading QIAGEN Digital Insights, where he scaled the business to nearly $100 million in revenue.
Tom Donnelly, CEO of Supreme Group, emphasized that Dr. Felciano's scientific and strategic vision will accelerate the company's AI platform development, enhancing its ability to deliver impactful solutions for clients and agencies. Dr. Felciano expressed enthusiasm for supporting Supreme Group's agencies in elevating their creative and strategic capabilities to better connect life sciences companies with researchers and clinicians globally.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 17 Masimo Gets FDA Clearance for AFib Detection on Radius VSM Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflowsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Level AI Adds Shane Abeyratne to CX Advisory Board
Jarrard Expands AI Consulting Team
Quotient Sciences and Acesion Apply AI to Atrial Fibrillation Drugs
Deerborne Survey Finds AI Cuts Analysis Workload, Not Decision Quality
Domino Data Lab and EPAM Partner on Validated AI for Life Sciences
Daily AI Brief: the AI news that matters, in your inbox.